|
1
|
Sontheimer H: Malignant gliomas:
Perverting glutamate and ion homeostasis for selective advantage.
Trends Neurosci. 26:543–549. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jentsch TJ: Discovery of CLC transport
proteins: Cloning, structure, function and pathophysiology. J
Physiol. 593:4091–4109. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leanza L, Biasutto L, Managò A, Gulbins E,
Zoratti M and Szabò I: Intracellular ion channels and cancer. Front
Physiol. 4:2272013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li X, Wang T, Zhao Z and Weinman SA: The
ClC-3 chloride channel promotes acidification of lysosomes in
CHO-K1 and Huh-7 cells. Am J Physiol Cell Physiol. 282:C1483–C1491.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hara-Chikuma M, Yang B, Sonawane ND,
Sasaki S, Uchida S and Verkman AS: ClC-3 chloride channels
facilitate endosomal acidification and chloride accumulation. J
Biol Chem. 280:1241–1247. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weylandt KH, Nebrig M, Jansen-Rosseck N,
Amey JS, Carmena D, Wiedenmann B, Higgins CF and Sardini A: ClC-3
expression enhances etoposide resistance by increasing
acidification of the late endocytic compartment. Mol Cancer Ther.
6:979–986. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zifarelli G and Pusch M: CLC chloride
channels and transporters: A biophysical and physiological
perspective. Rev Physiol Biochem Pharmacol. 158:23–76.
2007.PubMed/NCBI
|
|
8
|
Hong S, Bi M, Wang L, Kang Z, Ling L and
Zhao C: CLC-3 channels in cancer (review). Oncol Rep. 33:507–514.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lui VC, Lung SS, Pu JK, Hung KN and Leung
GK: Invasion of human glioma cells is regulated by multiple
chloride channels including ClC-3. Anticancer Res. 30:4515–4524.
2010.PubMed/NCBI
|
|
10
|
Rosenberg B: Fundamental studies with
cisplatin. Cancer. 55:2303–23l6. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Madajewicz S, Chowhan N, Tfayli A, Roque
C, Meek A, Davis R, Wolf W, Cabahug C, Roche P, Manzione J, et al:
Therapy for patients with high grade astrocytoma using
intraarterial chemotherapy and radiation therapy. Cancer.
88:2350–2356. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Safaei R, Katano K, Larson BJ, Samimi G,
Holzer AK, Naerdemann W, Tomioka M, Goodman M and Howell SB:
Intracellular localization and trafficking of fluorescein-labeled
cisplatin in human ovarian carcinoma cells. Clin Cancer Res.
11:756–767. 2005.PubMed/NCBI
|
|
13
|
Liang XJ, Mukherjee S, Shen DW, Maxfield
FR and Gottesman MM: Endocytic recycling compartments altered in
cisplatin-resistant cancer cells. Cancer Res. 66:2346–2353. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Safaei R and Howell SB: Copper
transporters regulate the cellular pharmacology and sensitivity to
Pt drugs. Crit Rev Oncol Hematol. 53:13–23. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liao C, Hu B, Arno MJ and Panaretou B:
Genomic screening in vivo reveals the role played by vacuolar H+
ATPase and cytosolic acidification in sensitivity to DNA-damaging
agents such as cisplatin. Mol Pharmacol. 71:416–425. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shimada K, Li X, Xu G, Nowak DE, Showalter
LA and Weinman SA: Expression and canalicular localization of two
isoforms of the ClC-3 chloride channel from rat hepatocytes. Am J
Physiol Gastrointest Liver Physiol. 279:G268–G276. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Olsen ML, Schade S, Lyons SA, Amaral MD
and Sontheimer H: Expression of voltage-gated chloride channels in
human glioma cells. J Neurosci. 23:5572–5582. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu SJ, Quan C, Li F, Vida L and Honig GR:
Hematopoietic progenitor cells derived from embryonic stem cells:
Analysis of gene expression. Stem Cells. 20:428–437. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mizel SB: Interleukin 1 and T cell
activation. Immunol Rev. 63:51–72. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Niinuma A, Higuchi M, Takahashi M, Oie M,
Tanaka Y, Gejyo F, Tanaka N, Sugamura K, Xie L, Green PL and Fujii
M: Aberrant activation of the interleukin-2 autocrine loop through
the nuclear factor of activated T cells by nonleukemogenic human
T-cell leukemia virus type 2 but not by leukemogenic type 1 virus.
J Virol. 79:11925–11934. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Duan L, Aoyagi M, Tamaki M, Nakagawa K,
Nagashima G, Nagasaka Y, Ohno K, Yamamoto K and Hirakawa K:
Sensitization of human malignant glioma cell lines to tumor
necrosis factor-induced apoptosis by cisplatin. J Neurooncol.
52:23–36. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Millot C, Millot JM, Morjani H, Desplaces
A and Manfait M: Characterization of acidic vesicles in
multidrug-resistant and sensitive cancer cells by acridine orange
staining and confocal microspectrofluorometry. J Histochem
Cytochem. 45:1255–1264. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Su J, Xu Y, Zhou L, Yu HM, Kang JS, Liu N,
Quan CS and Sun LK: Suppression of chloride channel 3 expression
facilitates sensitivity of human glioma U251 cells to cisplatin
through concomitant inhibition of Akt and autophagy. Anat Rec
(Hoboken). 296:595–603. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Strojan P, Vermorken JB, Beitler JJ, Saba
NF, Haigentz M Jr, Bossi P, Worden FP, Langendijk JA, Eisbruch A,
Mendenhall WM, et al: Cumulative cisplatin dose in concurrent
chemoradiotherapy for head and neck cancer: A systematic review.
Head Neck. 38 Suppl 1:E2151–E2158. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Borst P, Rottenberg S and Jonkers J: How
do real tumors become resistant to cisplatin? Cell Cycle.
7:1353–1359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mao J, Chen L, Xu B and Wang L, Li H, Guo
J, Li W, Nie S, Jacob TJ and Wang L: Suppression of ClC-3 channel
expression reduces migration of nasopharyngeal carcinoma cells.
Biochem Pharmacol. 75:1706–1716. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sontheimer H: An unexpected role for ion
channels in brain tumor metastasis. Exp Biol Med (Maywood).
233:779–791. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Habela CW, Olsen ML and Sontheimer H: ClC3
is a critical regulator of the cell cycle in normal and malignant
glial cells. J Neurosci. 28:9205–9217. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moreland JG, Davis AP, Bailey G, Nauseef
WM and Lamb FS: Anion channels, including ClC-3, are required for
normal neutrophil oxidative function, phagocytosis, and
transendothelial migration. J Biol Chem. 281:12277–12288. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shimizu T, Lee EL, Ise T and Okada Y:
Volume-sensitive Cl(−) channel as a regulator of acquired cisplatin
resistance. Anticancer Res. 28:75–83. 2008.PubMed/NCBI
|
|
31
|
Safaei R, Larson BJ, Cheng TC, Gibson MA,
Otani S, Naerdemann W and Howell SB: Abnormal lysosomal trafficking
and enhanced exosomal export of cisplatin in drug-resistant human
ovarian carcinoma cells. Mol Cancer Ther. 4:1595–1604. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chauhan SS, Liang XJ, Su AW,
Pai-Panandiker A, Shen DW, Hanover JA and Gottesman MM: Reduced
endocytosis and altered lysosome function in cisplatin-resistant
cell lines. Br J Cancer. 88:1327–1334. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Garmann D, Warnecke A, Kalayda GV, Kratz F
and Jaehde U: Cellular accumulation and cytotoxicity of
macromolecular platinum complexes in cisplatin-resistant tumor
cells. J Control Release. 131:100–106. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yarbrough JW, Merryman JI, Barnhill MA and
Hahn KA: Inhibitors of intracellular chloride regulation induce
cisplatin resistance in canine osteosarcoma cells. In Vivo.
13:375–383. 1999.PubMed/NCBI
|
|
35
|
Lee EL, Shimizu T, Ise T, Numata T, Kohno
K and Okada Y: Impaired activity of volume-sensitive Cl-channel is
involved in cisplatin resistance of cancer cells. J Cell Physiol.
211:513–521. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ashkenazi A: Targeting death and decoy
receptors of the tumour-necrosis factor superfamily. Nat Rev
Cancer. 2:420–430. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jiang X and Wang X: Cytochrome C-mediated
apoptosis. Annu Rev Biochem. 73:87–106. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Burger H, Nooter K, Boersma AW, Kortland
CJ and Stoter G: Expression of p53, Bcl-2 and Bax in
cisplatin-induced apoptosis in testicular germ cell tumour cell
lines. Br J Cancer. 77:1562–1567. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jäättelä M, Candé C and Kroemer G:
Lysosomes and mitochondria in the commitment to apoptosis: A
potential role for cathepsin D and AIF. Cell Death Differ.
11:135–136. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Boya P and Kroemer G: Lysosomal membrane
permeabilization in cell death. Oncogene. 27:6434–6451. 2008.
View Article : Google Scholar : PubMed/NCBI
|
